Bioventus (BVS) Net Equity Issued and Repurchased (2021 - 2026)
Bioventus' (BVS) quarterly Net Equity Issued and Repurchased came in at $120000.0 in Q1 2026, down 20.0% YoY from $150000.0 in Q1 2025, and down 76.52% on a QoQ basis from $511000.0 in Q4 2025.
Bioventus (BVS) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
Bioventus (BVS) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $120000.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 20.0% year-over-year to $120000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 15.36% YoY) and the FY2025 annual result came in at $2.1 million, down 15.07% from the prior year.
- Net Equity Issued and Repurchased declined to $120000.0 in Q1 2026, from $511000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $2.2 million in Q3 2022 to a low of $84000.0 in Q2 2023.
- A 5-year average of $660941.2 and a median of $482000.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased soared 12900.0% — and 2023, when it tumbled 95.96%.
- Tracing BVS's Net Equity Issued and Repurchased over 5 years: stood at $1.1 million in 2022, then tumbled by 85.41% to $158000.0 in 2023, then soared by 598.1% to $1.1 million in 2024, then tumbled by 53.67% to $511000.0 in 2025, then sank by 76.52% to $120000.0 in 2026.
- The last three Net Equity Issued and Repurchased figures came in at $120000.0 (Q1 2026), $511000.0 (Q4 2025), and $96000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Bioventus | 972.23 Mn | 942.77 Mn | 105.67 Mn | 853,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 853,000.00 |
| Jun 27, 2026 | 853,000.00 |
| Mar 28, 2026 | 120,000.00 |
| Mar 28, 2026 | 120,000.00 |
| Dec 31, 2025 | 511,000.00 |
| Dec 31, 2025 | 511,000.00 |
| Sep 27, 2025 | 96,000.00 |
| Sep 27, 2025 | 96,000.00 |
| Jun 28, 2025 | 1.32 Mn |
| Jun 28, 2025 | 1.32 Mn |
| Mar 29, 2025 | 150,000.00 |
| Mar 29, 2025 | 150,000.00 |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 28, 2024 | 553,000.00 |
| Sep 28, 2024 | 553,000.00 |
| Jun 29, 2024 | 609,000.00 |
| Jun 29, 2024 | 609,000.00 |
| Mar 30, 2024 | 177,000.00 |
| Mar 30, 2024 | 177,000.00 |